- Home
- PLSE vs AAMI Comparison
PLSE vs AAMI Comparison
Compare PLSE & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- AAMI
- Stock Information
- Founded
- PLSE 2014
- AAMI 1980
- Country
- PLSE United States
- AAMI United States
- Employees
- PLSE N/A
- AAMI N/A
- Industry
- PLSE Medical/Dental Instruments
- AAMI Investment Managers
- Sector
- PLSE Health Care
- AAMI Finance
- Exchange
- PLSE Nasdaq
- AAMI Nasdaq
- Market Cap
- PLSE 1.2B
- AAMI 964.3M
- IPO Year
- PLSE 2016
- AAMI N/A
- Fundamental
- Price
- PLSE $19.74
- AAMI $25.37
- Analyst Decision
- PLSE
- AAMI
- Analyst Count
- PLSE 0
- AAMI 0
- Target Price
- PLSE N/A
- AAMI N/A
- AVG Volume (30 Days)
- PLSE 133.6K
- AAMI 169.0K
- Earning Date
- PLSE 10-30-2024
- AAMI 02-06-2025
- Dividend Yield
- PLSE N/A
- AAMI 0.16%
- EPS Growth
- PLSE N/A
- AAMI N/A
- EPS
- PLSE N/A
- AAMI 1.65
- Revenue
- PLSE N/A
- AAMI $469,000,000.00
- Revenue This Year
- PLSE N/A
- AAMI $16.77
- Revenue Next Year
- PLSE N/A
- AAMI $8.38
- P/E Ratio
- PLSE N/A
- AAMI $15.34
- Revenue Growth
- PLSE N/A
- AAMI 12.17
- 52 Week Low
- PLSE $6.60
- AAMI $20.18
- 52 Week High
- PLSE $22.69
- AAMI $31.52
- Technical
- Relative Strength Index (RSI)
- PLSE 58.11
- AAMI N/A
- Support Level
- PLSE $17.35
- AAMI N/A
- Resistance Level
- PLSE $19.90
- AAMI N/A
- Average True Range (ATR)
- PLSE 1.05
- AAMI 0.00
- MACD
- PLSE 0.15
- AAMI 0.00
- Stochastic Oscillator
- PLSE 80.47
- AAMI 0.00
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.